Citigroup’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-9,423
| Closed | -$44K | – | 5254 |
|
|
2019
Q1 | $44K | Buy |
9,423
+2,988
| +46% | +$14K | ﹤0.01% | 4112 |
|
|
2018
Q4 | $22K | Sell |
6,435
-2,901
| -31% | -$9.92K | ﹤0.01% | 4385 |
|
|
2018
Q3 | $94K | Buy |
9,336
+6,269
| +204% | +$63.1K | ﹤0.01% | 3640 |
|
|
2018
Q2 | $22K | Sell |
3,067
-2,144
| -41% | -$15.4K | ﹤0.01% | 4357 |
|
|
2018
Q1 | $32K | Sell |
5,211
-48
| -0.9% | -$295 | ﹤0.01% | 4005 |
|
|
2017
Q4 | $50K | Sell |
5,259
-8,510
| -62% | -$80.9K | ﹤0.01% | 3810 |
|
|
2017
Q3 | $123K | Buy |
13,769
+4,373
| +47% | +$39.1K | ﹤0.01% | 3240 |
|
|
2017
Q2 | $119K | Sell |
9,396
-171
| -2% | -$2.17K | ﹤0.01% | 3203 |
|
|
2017
Q1 | $100K | Sell |
9,567
-54,347
| -85% | -$568K | ﹤0.01% | 3349 |
|
|
2016
Q4 | $587K | Buy |
63,914
+32,964
| +107% | +$303K | ﹤0.01% | 2772 |
|
|
2016
Q3 | $365K | Buy |
30,950
+12,439
| +67% | +$147K | ﹤0.01% | 2635 |
|
|
2016
Q2 | $240K | Sell |
18,511
-4,309
| -19% | -$55.9K | ﹤0.01% | 2733 |
|
|
2016
Q1 | $365K | Buy |
22,820
+14,197
| +165% | +$227K | ﹤0.01% | 2973 |
|
|
2015
Q4 | $247K | Sell |
8,623
-21,822
| -72% | -$625K | ﹤0.01% | 2898 |
|
|
2015
Q3 | $866K | Buy |
30,445
+5,552
| +22% | +$158K | ﹤0.01% | 1828 |
|
|
2015
Q2 | $894K | Sell |
24,893
-385
| -2% | -$13.8K | ﹤0.01% | 1800 |
|
|
2015
Q1 | $735K | Sell |
25,278
-4,930
| -16% | -$143K | ﹤0.01% | 1981 |
|
|
2014
Q4 | $637K | Buy |
30,208
+11,556
| +62% | +$244K | ﹤0.01% | 2222 |
|
|
2014
Q3 | $362K | Buy |
18,652
+16,048
| +616% | +$311K | ﹤0.01% | 2232 |
|
|
2014
Q2 | $41K | Sell |
2,604
-4,558
| -64% | -$71.8K | ﹤0.01% | 3685 |
|
|
2014
Q1 | $148K | Sell |
7,162
-2,132
| -23% | -$44.1K | ﹤0.01% | 3152 |
|
|
2013
Q4 | $120K | Buy |
9,294
+9,270
| +38,625% | +$120K | ﹤0.01% | 3577 |
|
|
2013
Q3 | $0 | Buy |
+24
| New | – | ﹤0.01% | 5375 |
|